129 related articles for article (PubMed ID: 16925736)
1. Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use.
Winston J; Shepp DH
HIV Med; 2006 Oct; 7(7):484-5. PubMed ID: 16925736
[No Abstract] [Full Text] [Related]
2. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.
Malik A; Abraham P; Malik N
J Infect; 2005 Aug; 51(2):E61-5. PubMed ID: 16038754
[TBL] [Abstract][Full Text] [Related]
3. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
Psevdos G; Gonzalez E; Sharp V
AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
[TBL] [Abstract][Full Text] [Related]
4. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
[TBL] [Abstract][Full Text] [Related]
5. Causes and consequences of hypokalemia in patients on tenofovir disoproxil fumarate.
Shepp DH; Curtis S; Rooney JF
AIDS; 2007 Jul; 21(11):1479-81. PubMed ID: 17589195
[TBL] [Abstract][Full Text] [Related]
6. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
Parsonage MJ; Wilkins EG; Snowden N; Issa BG; Savage MW
HIV Med; 2005 Sep; 6(5):341-6. PubMed ID: 16156882
[TBL] [Abstract][Full Text] [Related]
7. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
Gallant JE; Parish MA; Keruly JC; Moore RD
Clin Infect Dis; 2005 Apr; 40(8):1194-8. PubMed ID: 15791522
[TBL] [Abstract][Full Text] [Related]
8. Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature.
Quimby D; Brito MO
AIDS Read; 2005 Jul; 15(7):357-64. PubMed ID: 16044577
[TBL] [Abstract][Full Text] [Related]
9. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
Gupta Samir K
AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
[No Abstract] [Full Text] [Related]
10. Editorial comment: tenofovir nephrotoxicity--vigilance required.
Fine DM
AIDS Read; 2005 Jul; 15(7):362-3. PubMed ID: 16044578
[No Abstract] [Full Text] [Related]
11. Effect of tenofovir on renal glomerular and tubular function.
Fux CA; Christen A; Zgraggen S; Mohaupt MG; Furrer H
AIDS; 2007 Jul; 21(11):1483-5. PubMed ID: 17589197
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir and changes in renal function.
Flandre P
AIDS; 2010 Feb; 24(4):619-20. PubMed ID: 20195075
[No Abstract] [Full Text] [Related]
13. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
Gérard L; Chazallon C; Taburet AM; Girard PM; Aboulker JP; Piketty C
Antivir Ther; 2007; 12(1):31-9. PubMed ID: 17503745
[TBL] [Abstract][Full Text] [Related]
14. Meeting notes from ICAAC. Tenofovir + ddI: a combination to avoid.
Sax PE
AIDS Clin Care; 2005 Jan; 17(1):6-7. PubMed ID: 15717372
[No Abstract] [Full Text] [Related]
15. Renal safety of tenofovir disoproxil fumarate.
Sax PE; Gallant JE; Klotman PE
AIDS Read; 2007 Feb; 17(2):90-2, 99-104, C3. PubMed ID: 17323508
[TBL] [Abstract][Full Text] [Related]
16. Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.
Atta MG; Fine DM
AIDS Read; 2009 Mar; 19(3):118-9. PubMed ID: 19334329
[No Abstract] [Full Text] [Related]
17. Improvement in chronic renal impairment following the discontinuation of tenofovir in two HIV-infected patients.
Gracey D; Post J; MacLeod C; McKenzie P
Nephrology (Carlton); 2011 May; 16(4):453-5. PubMed ID: 21518120
[No Abstract] [Full Text] [Related]
18. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
Perrot S; Aslangul E; Szwebel T; Caillat-Vigneron N; Le Jeunne C
J Clin Rheumatol; 2009 Mar; 15(2):72-4. PubMed ID: 19265350
[TBL] [Abstract][Full Text] [Related]
19. Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this?
Gupta SK
AIDS Read; 2009; 19(6):246. PubMed ID: 19642244
[No Abstract] [Full Text] [Related]
20. Serum creatinine changes in HIV-seropositive patients receiving tenofovir.
El Sahly HM; Teeter L; Zerai T; Andrade RA; Munoz C; Nnabuife C; Hunter R
AIDS; 2006 Mar; 20(5):786-7. PubMed ID: 16514316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
